Original paper
Molecular genetic analysis of the von Hippel-Lindau disease (VHl) tumour suppressor gene in gonadal tumours

https://doi.org/10.1016/0959-8049(95)00437-8Get rights and content

Abstract

Chromosome 3p allele loss is frequent in ovarian and testicular tumours. The von Hippel-Lindau (VHL) disease tumour suppressor gene maps to chromosome 3p25. Gonadal tumours may occur in patients with VHL disease, so somatic VHL gene mutations might be involved in the pathogenesis of sporadic gonadal tumours. To investigate this hypothesis, we screened 60 gonadal tumours (36 ovarian and 24 testicular) for VHL gene mutations and chromosome 3p allele loss. Although 38% (1026) of informative ovarian and 54% (713) of testicular tumours demonstrated 3p allele loss, no somatic VHL gene mutations were detected in the 60 gonadal tumours analysed. This suggested that chromosome 3p tumour suppressor gene(s) other than VHL are involved in gonadal tumorigenesis.

References (30)

  • M Cendron et al.

    Germ cell tumor of testis in a patient with von Hippel-Lindau disease

    Urology

    (1991)
  • BR Seizinger et al.

    Report of the committee on chromosome and gene loss in human neoplasia

    Cytogenet Cell Genet

    (1991)
  • K Yamakawa et al.

    A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma

    Cancer Res

    (1991)
  • P Anglard et al.

    Molecular and cellular characterization of human renal cell carcinoma cell lines

    Cancer Res

    (1992)
  • F Latif et al.

    Molecular characterization of a large homozygous deletion in the small cell lung cancer cell line U2020: a strategy for cloning the putative tumor suppressor gene

    Genes, Chromosomes and Cancer

    (1992)
  • K Yamakawa et al.

    Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3–p22

    Oncogene

    (1993)
  • K Foster et al.

    Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22

    Br J Cancer

    (1994)
  • K Kok et al.

    A homozygous deletion in small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes

    Cancer Res

    (1994)
  • F Latif et al.

    Identification of the von Hippel-Lindau disease tumour suppressor gene

    Science

    (1993)
  • ER Maher et al.

    Clinical features and natural history of von Hippel-Lindau disease

    Quart J Med

    (1990)
  • PA Crossey et al.

    Molecular genetic investigation of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours

    Hum Genet

    (1994)
  • K Foster et al.

    Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in nonfamilial clear cell renal carcinoma

    Hum Molec Genet

    (1994)
  • JR Gnarra et al.

    Mutations of the VHL tumour suppressor gene in renal carcinoma

    Nature Genet

    (1994)
  • T Shuin et al.

    Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas

    Cancer Res

    (1994)
  • JM Whaley et al.

    Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma

    Am J Hum Genet

    (1994)
  • Cited by (21)

    • Tumor-suppressive function of protein-tyrosine phosphatase non-receptor type 23 in testicular germ cell tumors is lost upon over expression of miR142-3p microRNA

      2013, Journal of Biological Chemistry
      Citation Excerpt :

      An isochromosome of the short arm of chromosome 12 is the most common and characteristic cytogenetic aberration in TGCTs. In addition, molecular genetic changes in human TGCTs showed 3p allele loss, suggesting the presence of a tumor suppressor gene within this region (13–15). Notably, the PTPN23 gene is located within this region (chromosome 3p21.3) in an area of the genome frequently lost in breast (16), lung (17), nasopharyngeal (18), cervical (19), and kidney (20) carcinomas.

    • Role of VHL gene mutation in human cancer

      2004, Journal of Clinical Oncology
    View all citing articles on Scopus
    View full text